Inhibition of factor XIIIa-mediated incorporation of fibronectin into fibrin by pulmonary surfactant.
Intra-alveolar deposition of exudated plasma proteins is a hallmark of acute and chronic inflammatory lung diseases. In particular, fibrin and fibronectin may provide a primary matrix for fibrotic lung remodeling in the alveolar compartment. The present study was undertaken to explore the effect of two surfactant preparations on the incorporation of fibronectin into fibrin. We observed that surfactant phospholipids are associated with insoluble fibrin, factor XIIIa-cross-linked fibrin, and cross-linked fibrin with incorporated fibronectin. Factor XIIIa-mediated binding of fibronectin to fibrin was noticeably altered in the presence of surfactant. Coincubation with two different commercially available surfactants but not with dipalmitoylphosphatidylcholine alone resulted in a reduction of fibronectin incorporation into fibrin clots by approximately one-third. This effect was not dependent on the calcium concentration. We conclude that 1) factor XIIIa-cross-linked fibrin-fibronectin is able to incorporate surfactant phospholipids in amounts comparable to fibrin clots without fibronectin and 2) the binding of fibronectin to fibrin is partially inhibited in the presence of pulmonary surfactant.
Elssner
A
A
Division for Pulmonary Diseases, Department of Internal Medicine I, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, 81377 Munich, Germany. Andreas.Ellsner@med1.med.uni-muenchen.de
Mazur
G
G
Vogelmeier
C
C
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000494:pharmacology; D000818:Animals; D002417:Cattle; D004591:Electrophoresis, Polyacrylamide Gel; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000302:isolation & purification / Q000378:metabolism; D005353:Fibronectins / Q000378:metabolism*; D007700:Kinetics; D011658:Pulmonary Fibrosis / Q000503:physiopathology; D011663:Pulmonary Surfactants / Q000494:pharmacology / Q000502:physiology*; D013552:Swine; D011503:Transglutaminases / Q000037:antagonists & inhibitors / Q000378:metabolism*
D005353:Fibronectins; D011663:Pulmonary Surfactants; D015060:1,2-Dipalmitoylphosphatidylcholine; D005337:Fibrin; D005340:Fibrinogen; D011503:Transglutaminases